United States Inactivated Vaccines Market Report 2021
Notes:
Sales, means the sales volume of Inactivated Vaccines
Revenue, means the sales value of Inactivated Vaccines
This report studies sales (consumption) of Inactivated Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sales, means the sales volume of Inactivated Vaccines
Revenue, means the sales value of Inactivated Vaccines
This report studies sales (consumption) of Inactivated Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
- Astellas Pharma Inc
- CSL Limited
- Emergent BioSolutions, Inc
- GlaxoSmithKline
- Johnson & Johnson
- MedImmune, LLC
- Merck & Co
- Pfizer
- Sanofi Pasteur
- Serum Institute
- India Pvt. Ltd. (India)
- Pneumococcal
- Influenza
- HPV
- Hepatitis
- Rotavirus
- DTP
- Polio
- MMR
- Pediatric
- Adult
- Application 3
United States Inactivated Vaccines Market Report 2021
1 INACTIVATED VACCINES OVERVIEW
1.1 Product Overview and Scope of Inactivated Vaccines
1.2 Classification of Inactivated Vaccines
1.2.1 Pneumococcal
1.2.2 Influenza
1.2.3 HPV
1.2.4 Hepatitis
1.2.5 Rotavirus
1.2.6 DTP
1.2.7 Polio
1.2.8 MMR
1.3 Applications of Inactivated Vaccines
1.3.1 Pediatric
1.3.2 Adult
1.3.3 Application
1.4 USA Market Size (Value and Volume) of Inactivated Vaccines (2011-2021)
1.4.1 USA Inactivated Vaccines Sales, Revenue and Price (2011-2021)
1.4.2 USA Inactivated Vaccines Sales and Growth Rate (2011-2021)
1.4.3 USA Inactivated Vaccines Revenue and Growth Rate (2011-2021)
2 USA INACTIVATED VACCINES COMPETITION BY MANUFACTURERS
2.1 USA Inactivated Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Inactivated Vaccines Revenue and Share by Manufactures (2015 and 2016)
3 USA INACTIVATED VACCINES (VOLUME AND VALUE) BY TYPE
3.1 USA Inactivated Vaccines Sales and Market Share by Type (2011-2021)
3.2 USA Inactivated Vaccines Revenue and Market Share by Type (2011-2021)
4 USA INACTIVATED VACCINES (VOLUME) BY APPLICATION
5 USA INACTIVATED VACCINES MANUFACTURERS ANALYSIS
5.1 Astellas Pharma Inc
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Inactivated Vaccines Product Type and Technology
5.1.2.1 Pneumococcal
5.1.2.2 Influenza
5.1.3 Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
5.2 CSL Limited
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Pneumococcal
5.2.2.2 Influenza
5.2.3 Pharmaceuticals Sales, Revenue, Price of CSL Limited (2015 and 2016)
5.3 Emergent BioSolutions, Inc
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Emergent BioSolutions, Inc Product Type and Technology
5.3.2.1 Pneumococcal
5.3.2.2 Influenza
5.3.3 Emergent BioSolutions, Inc Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
5.4 GlaxoSmithKline
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Sanofi Pasteur Product Type and Technology
5.4.2.1 Pneumococcal
5.4.2.2 Influenza
5.4.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.5 Johnson & Johnson
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Johnson & Johnson Product Type and Technology
5.5.2.1 Pneumococcal
5.5.2.2 Influenza
5.5.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.6 MedImmune, LLC
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 MedImmune, LLC Product Type and Technology
5.6.2.1 Pneumococcal
5.6.2.2 Influenza
5.6.3 MedImmune, LLC Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
5.7 Merck & Co
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Merck & Co Product Type and Technology
5.7.2.1 Pneumococcal
5.7.2.2 Influenza
5.7.3 Merck & Co Sales, Revenue, Price of Merck & Co (2015 and 2016)
5.8 Pfizer
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Pfizer Product Type and Technology
5.8.2.1 Pneumococcal
5.8.2.2 Influenza
5.8.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.9 Sanofi Pasteur
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 Sanofi Pasteur Product Type and Technology
5.9.2.1 Pneumococcal
5.9.2.2 Influenza
5.9.3 Sanofi Pasteur Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
5.10 Serum Institute
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Serum Institute Product Type and Technology
5.10.2.1 Pneumococcal
5.10.2.2 Influenza
5.10.3 Serum Institute Sales, Revenue, Price of Serum Institute (2015 and 2016)
5.11 India Pvt. Ltd. (India)
6 INACTIVATED VACCINES TECHNOLOGY AND DEVELOPMENT TREND
6.1 Inactivated Vaccines Technology Analysis
6.2 Inactivated Vaccines Technology Development Trend
7 RESEARCH FINDINGS AND CONCLUSION
1 INACTIVATED VACCINES OVERVIEW
1.1 Product Overview and Scope of Inactivated Vaccines
1.2 Classification of Inactivated Vaccines
1.2.1 Pneumococcal
1.2.2 Influenza
1.2.3 HPV
1.2.4 Hepatitis
1.2.5 Rotavirus
1.2.6 DTP
1.2.7 Polio
1.2.8 MMR
1.3 Applications of Inactivated Vaccines
1.3.1 Pediatric
1.3.2 Adult
1.3.3 Application
1.4 USA Market Size (Value and Volume) of Inactivated Vaccines (2011-2021)
1.4.1 USA Inactivated Vaccines Sales, Revenue and Price (2011-2021)
1.4.2 USA Inactivated Vaccines Sales and Growth Rate (2011-2021)
1.4.3 USA Inactivated Vaccines Revenue and Growth Rate (2011-2021)
2 USA INACTIVATED VACCINES COMPETITION BY MANUFACTURERS
2.1 USA Inactivated Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Inactivated Vaccines Revenue and Share by Manufactures (2015 and 2016)
3 USA INACTIVATED VACCINES (VOLUME AND VALUE) BY TYPE
3.1 USA Inactivated Vaccines Sales and Market Share by Type (2011-2021)
3.2 USA Inactivated Vaccines Revenue and Market Share by Type (2011-2021)
4 USA INACTIVATED VACCINES (VOLUME) BY APPLICATION
5 USA INACTIVATED VACCINES MANUFACTURERS ANALYSIS
5.1 Astellas Pharma Inc
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Inactivated Vaccines Product Type and Technology
5.1.2.1 Pneumococcal
5.1.2.2 Influenza
5.1.3 Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
5.2 CSL Limited
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Pneumococcal
5.2.2.2 Influenza
5.2.3 Pharmaceuticals Sales, Revenue, Price of CSL Limited (2015 and 2016)
5.3 Emergent BioSolutions, Inc
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Emergent BioSolutions, Inc Product Type and Technology
5.3.2.1 Pneumococcal
5.3.2.2 Influenza
5.3.3 Emergent BioSolutions, Inc Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
5.4 GlaxoSmithKline
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Sanofi Pasteur Product Type and Technology
5.4.2.1 Pneumococcal
5.4.2.2 Influenza
5.4.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.5 Johnson & Johnson
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Johnson & Johnson Product Type and Technology
5.5.2.1 Pneumococcal
5.5.2.2 Influenza
5.5.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.6 MedImmune, LLC
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 MedImmune, LLC Product Type and Technology
5.6.2.1 Pneumococcal
5.6.2.2 Influenza
5.6.3 MedImmune, LLC Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
5.7 Merck & Co
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Merck & Co Product Type and Technology
5.7.2.1 Pneumococcal
5.7.2.2 Influenza
5.7.3 Merck & Co Sales, Revenue, Price of Merck & Co (2015 and 2016)
5.8 Pfizer
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Pfizer Product Type and Technology
5.8.2.1 Pneumococcal
5.8.2.2 Influenza
5.8.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.9 Sanofi Pasteur
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 Sanofi Pasteur Product Type and Technology
5.9.2.1 Pneumococcal
5.9.2.2 Influenza
5.9.3 Sanofi Pasteur Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
5.10 Serum Institute
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Serum Institute Product Type and Technology
5.10.2.1 Pneumococcal
5.10.2.2 Influenza
5.10.3 Serum Institute Sales, Revenue, Price of Serum Institute (2015 and 2016)
5.11 India Pvt. Ltd. (India)
6 INACTIVATED VACCINES TECHNOLOGY AND DEVELOPMENT TREND
6.1 Inactivated Vaccines Technology Analysis
6.2 Inactivated Vaccines Technology Development Trend
7 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Inactivated Vaccines
Table Classification of Inactivated Vaccines
Figure USA Sales Market Share of Inactivated Vaccines by Type in 2015
Figure Pneumococcal Picture
Figure Influenza Picture
Figure HPV Picture
Figure Hepatitis Picture
Figure Rotavirus Picture
Figure DTP Picture
Figure Polio Picture
Figure MMR Picture
Table Applications of Inactivated Vaccines
Figure USA Sales Market Share of Inactivated Vaccines by Application in 2015
Figure Pediatric Examples
Figure Adult Examples
Table USA Inactivated Vaccines Sales, Revenue and Price (2011-2021)
Figure USA Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure USA Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Table USA Inactivated Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Inactivated Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Inactivated Vaccines Sales Share by Manufacturers
Figure 2016 Inactivated Vaccines Sales Share by Manufacturers
Table USA Inactivated Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Inactivated Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Inactivated Vaccines Revenue Share by Manufacturers
Table 2016 USA Inactivated Vaccines Revenue Share by Manufacturers
Table USA Inactivated Vaccines Sales and Market Share by Type (2011-2021)
Table USA Inactivated Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Inactivated Vaccines by Type (2011-2021)
Figure USA Inactivated Vaccines Sales Growth Rate by Type (2011-2021)
Table USA Inactivated Vaccines Revenue and Market Share by Type (2011-2021)
Table USA Inactivated Vaccines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Inactivated Vaccines by Type (2011-2021)
Figure USA Inactivated Vaccines Revenue Growth Rate by Type (2011-2021)
Table USA Inactivated Vaccines Sales and Market Share by Application (2011-2021)
Table USA Inactivated Vaccines Sales Share by Application (2011-2021)
Figure Sales Market Share of Inactivated Vaccines by Application (2011-2021)
Figure USA Inactivated Vaccines Sales Growth Rate by Application (2011-2021)
Table Astellas Pharma Inc Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)
Figure Picture of Inactivated Vaccines
Table Classification of Inactivated Vaccines
Figure USA Sales Market Share of Inactivated Vaccines by Type in 2015
Figure Pneumococcal Picture
Figure Influenza Picture
Figure HPV Picture
Figure Hepatitis Picture
Figure Rotavirus Picture
Figure DTP Picture
Figure Polio Picture
Figure MMR Picture
Table Applications of Inactivated Vaccines
Figure USA Sales Market Share of Inactivated Vaccines by Application in 2015
Figure Pediatric Examples
Figure Adult Examples
Table USA Inactivated Vaccines Sales, Revenue and Price (2011-2021)
Figure USA Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure USA Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Table USA Inactivated Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Inactivated Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Inactivated Vaccines Sales Share by Manufacturers
Figure 2016 Inactivated Vaccines Sales Share by Manufacturers
Table USA Inactivated Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Inactivated Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Inactivated Vaccines Revenue Share by Manufacturers
Table 2016 USA Inactivated Vaccines Revenue Share by Manufacturers
Table USA Inactivated Vaccines Sales and Market Share by Type (2011-2021)
Table USA Inactivated Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Inactivated Vaccines by Type (2011-2021)
Figure USA Inactivated Vaccines Sales Growth Rate by Type (2011-2021)
Table USA Inactivated Vaccines Revenue and Market Share by Type (2011-2021)
Table USA Inactivated Vaccines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Inactivated Vaccines by Type (2011-2021)
Figure USA Inactivated Vaccines Revenue Growth Rate by Type (2011-2021)
Table USA Inactivated Vaccines Sales and Market Share by Application (2011-2021)
Table USA Inactivated Vaccines Sales Share by Application (2011-2021)
Figure Sales Market Share of Inactivated Vaccines by Application (2011-2021)
Figure USA Inactivated Vaccines Sales Growth Rate by Application (2011-2021)
Table Astellas Pharma Inc Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)
